Investing.com - Lifestance Health Group (NASDAQ: LFST) reported fourth quarter EPS of $-0.12, $0.03 worse than the analyst estimate of $-0.09. Revenue for the quarter came in at $280.6M versus the consensus estimate of $262.9M.
Guidance
Lifestance Health Group sees FY 2024 revenue of $1.19B-$1.24B versus the analyst consensus of $1.20B.
Lifestance Health Group's stock price closed at $6.70. It is up 2.29% in the last 3 months and up 39.87% in the last 12 months.
Lifestance Health Group saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Lifestance Health Group's stock price’s past reactions to earnings here.
According to InvestingPro, Lifestance Health Group's Financial Health score is "good performance".
Check out Lifestance Health Group's recent earnings performance, and Lifestance Health Group's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar